| __timestamp | BioMarin Pharmaceutical Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 406114000 |
| Thursday, January 1, 2015 | 402271000 | 449119000 |
| Friday, January 1, 2016 | 476593000 | 502892000 |
| Sunday, January 1, 2017 | 554336000 | 544156000 |
| Monday, January 1, 2018 | 604353000 | 683530000 |
| Tuesday, January 1, 2019 | 680924000 | 736942000 |
| Wednesday, January 1, 2020 | 737669000 | 854233000 |
| Friday, January 1, 2021 | 759375000 | 1451683000 |
| Saturday, January 1, 2022 | 854009000 | 1416967000 |
| Sunday, January 1, 2023 | 937300000 | 1343105000 |
| Monday, January 1, 2024 | 1009025000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, BioMarin's SG&A expenses grew by approximately 210%, reflecting a strategic investment in operational expansion. In contrast, Jazz Pharmaceuticals saw a staggering 230% increase, peaking in 2021 with a notable 1.45 billion in expenses. This surge highlights Jazz's aggressive market positioning and expansion efforts. By 2023, both companies demonstrated a slight reduction in growth rate, indicating a potential shift towards cost optimization. These trends not only underscore the dynamic nature of the pharmaceutical industry but also provide insights into how these companies are navigating market challenges and opportunities.
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and BioMarin Pharmaceutical Inc.
Comparing SG&A Expenses: Insmed Incorporated vs BioMarin Pharmaceutical Inc. Trends and Insights
Who Optimizes SG&A Costs Better? BioMarin Pharmaceutical Inc. or Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Vericel Corporation Trends and Insights
BioMarin Pharmaceutical Inc. and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Xencor, Inc. Trends and Insights
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Blueprint Medicines Corporation Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Opthea Limited
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alkermes plc
Jazz Pharmaceuticals plc and Veracyte, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or Iovance Biotherapeutics, Inc.